Redeye adds a new note to the previous analysis of Arocell on their website. See full here: Redeye.se
Redeye adds a new research note to AroCells previous analysis
read more
News
News
Monitoring CDK 4/6 Inhibitors in Breast Cancer
Inhibitors of Cyclin Dependent Kinases type 4 and 6 (CDK 4/6Is) have revolutionised the therapy of breast cancer. Combined with anti-oestrogen therapy they have significantly extended the mean and median life expectancies of women with breast cancer. This combination...
New Article in DI Life Science
Or read it at DI.se
IDL Biotech licensierar sin produktlinje för tumörmarkörer på den manuella plattformen radioimmunoassay till Beckman Coulter Diagnostics
IDL Biotech meddelar att de har tecknat ett avtal med Beckman Coulter om licensiering av IDL Biotechs samtliga tumörmarkörer på den manuella plattformen radioimmunoassay (IRMA). Licensavtalet ger Beckman Coulter globala försäljningsrättigheter och möjliggör för IDL...
IDL Biotech launches TUBEX TF in Kenya
On September 17, 2019, IDL Biotech will launch the company's rapid test for typhoid fever, TUBEX TF, in Kenya. Read more here
